Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TIGAR deficiency enhances cardiac resilience through epigenetic programming of Parkin expression
Yan Tang, Stanislovas S. Jankauskas, Li Liu, Xujun Wang, Alus M. Xiaoli, Fajun Yang, Gaetano Santulli, Daorong Feng, Jeffrey E. Pessin
Yan Tang, Stanislovas S. Jankauskas, Li Liu, Xujun Wang, Alus M. Xiaoli, Fajun Yang, Gaetano Santulli, Daorong Feng, Jeffrey E. Pessin
View: Text | PDF
Research Article Cardiology Cell biology Metabolism

TIGAR deficiency enhances cardiac resilience through epigenetic programming of Parkin expression

  • Text
  • PDF
Abstract

Mitochondrial dysfunction devastates the heart in major cardiovascular diseases, yet the mechanisms governing mitochondrial quality control remain elusive. We discovered that TIGAR (TP53-induced glycolysis and apoptosis regulator) deficiency established profound cardiac protection through developmental epigenetic programming of Parkin expression. Using mice with whole-body and cardiomyocyte-specific TIGAR knockout, we demonstrated remarkable cardioprotection following myocardial infarction with maintained ejection fraction, and complete resistance to diet-induced cardiac hypertrophy despite comparable weight gain. TIGAR deficiency triggered dramatic increases in Parkin expression across all somatic tissues except testes, where Parkin levels remained extraordinarily high (100-fold greater than cardiac levels) regardless of TIGAR status, revealing tissue-specific regulatory mechanisms. This protection was entirely Parkin dependent, as double-knockout mice lost all cardioprotective benefits. Crucially, adult TIGAR manipulation failed to alter Parkin levels, demonstrating that this pathway operated exclusively during critical developmental windows to program lifelong cardiac resilience. Whole-genome bisulfite sequencing identified reduced DNA methylation in Prkn intron 10 as the key regulatory mechanism, with CRISPR deletion dramatically increasing Parkin expression in multiple cell lines. Our findings reveal how early cardiac metabolism programs lifelong cardiac function through epigenetic mechanisms, and identify developmental metabolic programming as a potential therapeutic target for preventing both ischemic heart disease and metabolic cardiomyopathy.

Authors

Yan Tang, Stanislovas S. Jankauskas, Li Liu, Xujun Wang, Alus M. Xiaoli, Fajun Yang, Gaetano Santulli, Daorong Feng, Jeffrey E. Pessin

×

Figure 2

Parkin upregulation mediates cardiac protection in TKO and hTKO mice.

Options: View larger image (or click on image) Download as PowerPoint
Parkin upregulation mediates cardiac protection in TKO and hTKO mice.
(A...
(A–C) Parkin (Prkn) mRNA levels in gastrocnemius muscle (A), brain (B), and heart (C) of WT, TKO, Myh6Cre, hTKO, Parkin-knockout (PKO), and Parkin/TIGAR double-knockout (PTKO) mice determined by RT-qPCR. Data normalized to WT expression. (D) Western blot analysis of TIGAR and Parkin protein levels in gastrocnemius muscle, brain, and heart tissues from WT and TKO mice, with β-actin and VDAC as loading controls. (E) Detection of Parkin protein in gastrocnemius muscle and heart tissues from WT, TKO, Myh6Cre, hTKO, PKO, and PTKO mice by immunoprecipitation followed by immunoblotting. (F) Western blot analysis of mitophagy-related proteins, including Parkin, SQSTM1/p62, LC3B, and ubiquitinated proteins in heart mitochondrial fractions from fed and 24-hour-fasted WT and TKO mice. (G and H) Immunoblot analysis of Parkin protein levels in cytosolic fractions from heart tissues of fed and 24-hour-fasted WT (G) and TKO (H) mice, with GAPDH as loading control. (I–K) Echocardiographic assessment of left ventricular ejection fraction (EF) (I), mass (LVM) (J), and end-diastolic volume (LVEDV) (K) in 4-month-old male WT, TKO, PKO, and PTKO mice 4 weeks after MI. Data represent mean ± SD. Statistical significance was determined by 1-way ANOVA. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.0001; n = 5–10 per group.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts